TerrAscend Battles DOJ Over Cannabis Tax Refund in Federal Court
Multi-state operator challenges federal tax code 280E in high-stakes lawsuit that could reshape industry taxation landscape.
TerrAscend finds itself locked in a federal court battle with the Department of Justice over a tax refund claim related to Section 280E, the federal tax code provision that prevents cannabis companies from deducting standard business expenses. The lawsuit represents one of the most direct challenges to the punitive tax framework that has hampered cannabis operators' profitability for years.
Section 280E forces cannabis companies to pay effective tax rates often exceeding 70%, creating a massive competitive disadvantage compared to traditional businesses. The provision prohibits deductions for advertising, rent, salaries, and other routine operating expenses, leaving only cost of goods sold as deductible. This tax burden has consistently pressured margins across the sector, with operators like Curaleaf, Green Thumb Industries, and Cresco Labs reporting effective tax rates that would bankrupt most industries.
TerrAscend's legal challenge comes as the cannabis industry faces mounting pressure from oversupply in key markets and compressed wholesale pricing. The company operates across multiple states including New Jersey, Pennsylvania, and Maryland, markets where regulatory frameworks continue evolving rapidly. Any favorable ruling could establish precedent for broader industry tax relief, potentially unlocking millions in cash flow for operators struggling with current market conditions.
The timing proves critical as federal rescheduling discussions gain momentum in Washington. Moving cannabis from Schedule I to Schedule III would eliminate 280E restrictions entirely, but that process remains uncertain. TerrAscend's lawsuit provides an alternative pathway to challenge the current tax structure through judicial review rather than waiting for legislative or regulatory action.
The outcome carries implications beyond TerrAscend's balance sheet. A successful challenge could trigger similar lawsuits across the industry and force Congress to address cannabis taxation more comprehensively. For investors, the case represents both opportunity and risk - victory could boost sector-wide valuations, while defeat might solidify 280E's grip on industry profitability for years to come.